Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis

被引：0
|
作者：
William Strampel
Ronald Emkey
Roberto Civitelli
机构：
[1] Michigan State University College of Osteopathic Medicine,
[2] Emkey Arthritis and Osteoporosis Clinic,undefined
[3] Washington University School of Medicine,undefined
来源：
Drug Safety | 2007年 / 30卷
关键词：
Bisphosphonates; Alendronate; Zoledronic Acid; Osteonecrosis; Risedronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Bisphosphonates are the most commonly prescribed medications for the treatment of osteoporosis. Although evidence supports a good safety profile for these agents, numerous tolerability issues have been associated with their use. This review provides an overview of the safety issues associated with the nitrogen-containing class of bisphosphonates and discusses the potential effect of these issues on adherence. The review specifically considers upper gastrointestinal (UGI) adverse events (AEs), renal toxicity, influenza-like illness, osteonecrosis of the jaw and evidence on how to treat or prevent these events.
引用
收藏
页码：755 / 763
页数：8
相关论文
共 50 条
  • [41] Bisphosphonates in the treatment of osteoporosis - Principles and efficacy
    Papapoulos, SE
    ANNALES DE MEDECINE INTERNE, 2000, 151 (06): : 504 - 510
  • [42] Oral bisphosphonates in treatment of transient osteoporosis
    Kibbi, L.
    Touma, Z.
    Khoury, N.
    Arayssi, T.
    CLINICAL RHEUMATOLOGY, 2008, 27 (04) : 529 - 532
  • [43] EFFICACY OF BISPHOSPHONATES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Galesanu, C.
    Lisnic, N.
    Mocanu, V.
    Florescu, A.
    Loghin, A-I
    Galesanu, M-R
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S739 - S739
  • [44] Oral bisphosphonates in treatment of transient osteoporosis
    L. Kibbi
    Z. Touma
    N. Khoury
    T. Arayssi
    Clinical Rheumatology, 2008, 27 : 529 - 532
  • [45] ORAL BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS - A REVIEW
    FRANCIS, RM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (09): : 831 - 851
  • [46] Injectable bisphosphonates in the treatment of postmenopausal osteoporosis
    Sartori, L
    Adami, S
    Filipponi, P
    Crepaldi, G
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 15 (04) : 271 - 283
  • [47] Bisphosphonates for the treatment of postmenopausal osteoporosis: An update
    Cranney A.
    Adachi J.D.
    Clinical Reviews in Bone and Mineral Metabolism, 2007, 5 (3): : 145 - 152
  • [48] THE ROLE OF BISPHOSPHONATES IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS
    PAPAPOULOS, SE
    AMERICAN JOURNAL OF MEDICINE, 1993, 95 : S48 - S52
  • [49] Injectable bisphosphonates in the treatment of postmenopausal osteoporosis
    Leonardo Sartori
    Silvano Adami
    Paolo Filipponi
    Gaetano Crepaldi
    Aging Clinical and Experimental Research, 2003, 15 (4) : 271 - 283
  • [50] Systematic review of effectiveness and safety of bisphosphonates in the treatment of children with Juvenile Idiopathic Arthritis and osteoporosis
    Thomton, J.
    Ashcroft, D. M.
    Elliott, R.
    O'Neill, T. W.
    Symmons, D.
    RHEUMATOLOGY, 2006, 45 : I115 - I116
12345